Rates of bleeding were similar in the two groups ( @ -LSB- @ % -RSB- in the rituximab group vs @ -LSB- @ % -RSB- in the placebo group ; p = @ ) as were rates of infection ( @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ; p = @ ) .